≡

Multiplex Assay Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay)

CHR-NA1; N-AChRA1; NAChRA1; ACHRA; ACHRD; CMS2A; FCCMS; SCCMS; Acetylcholine receptor subunit alpha; N-AChR-A1; Neuronal Acetylcholine Receptor Alpha 1,Muscle

(Note: Up to 8-plex in one testing reaction)

Specificity

This assay has high sensitivity and excellent specificity for detection of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay).
No significant cross-reactivity or interference between Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) and the recovery rates were calculated by comparing the measured value to the expected amount of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 80-101 89
EDTA plasma(n=5) 97-105 101
heparin plasma(n=5) 87-101 96
sodium citrate plasma(n=5) 87-97 92

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 93-104% 78-101% 90-97% 89-99%
EDTA plasma(n=5) 78-104% 91-105% 88-95% 88-101%
heparin plasma(n=5) 80-97% 99-105% 79-104% 95-103%
sodium citrate plasma(n=5) 86-93% 87-105% 96-105% 80-101%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
96-well plate 1 Plate sealer for 96 wells 4
Pre-Mixed Standard 2 Standard Diluent 1×20mL
Pre-Mixed Magnetic beads (22#:CHRNa1) 1 Analysis buffer 1×20mL
Pre-Mixed Detection Reagent A 1×120μL Assay Diluent A 1×12mL
Detection Reagent B (PE-SA) 1×120μL Assay Diluent B 1×12mL
Sheath Fluid 1×10mL Wash Buffer (30 × concentrate) 1×20mL
Instruction manual 1

Assay procedure summary

1. Preparation of standards, reagents and samples before the experiment;
2. Add 100μL standard or sample to each well,
    add 10μL magnetic beads, and incubate 90min at 37°C on shaker;
3. Remove liquid on magnetic frame, add 100μL prepared Detection Reagent A. Incubate 60min at 37°C on shaker;
4. Wash plate on magnetic frame for three times;
5. Add 100μL prepared Detection Reagent B, and incubate 30 min at 37°C on shaker;
6. Wash plate on magnetic frame for three times;
7. Add 100μL sheath solution, swirl for 2 minutes, read on the machine.

GIVEAWAYS

INCREMENT SERVICES

Magazine Citations
International Journal of Peptides Effects of Endurance and Resistance Training on Calcitonin Gene-Related Peptide and Acetylcholine Receptor at Slow and Fast Twitch Skeletal Muscles and Sciatic Nerve in Male Wistar Rats PubMed: PMC3382945
Progress in Neuro-Psychopharmacology & Biological Psychiatry Effects of vortioxetine on biomarkers associated with glutamatergic activity in an SSRI insensitive model of depression in female rats pubmed:29269186
Saudi Pharmaceutical Journal Sukkari dates seed improves type-2 diabetes mellitus-induced memory impairment by reducing blood glucose levels and enhancing brain cholinergic … Pubmed:35812141
Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPA981Hu01 Recombinant Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) Positive Control; Immunogen; SDS-PAGE; WB.
PAA981Hu01 Polyclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) WB; IHC; ICC; IP.
MAA981Hu21 Monoclonal Antibody to Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) WB; IHC; ICC; IP.
SEA981Hu ELISA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) Enzyme-linked immunosorbent assay for Antigen Detection.
SCA981Hu CLIA Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) Chemiluminescent immunoassay for Antigen Detection.
LMA981Hu Multiplex Assay Kit for Cholinergic Receptor, Nicotinic, Alpha 1 (CHRNa1) ,etc. by FLIA (Flow Luminescence Immunoassay) FLIA Kit for Antigen Detection.